Stocks Hitting 52-Week Highs

MasTec, Inc. MTZ shares gained 16.7 percent to reach a new 52-week high of $28.42 after the company posted better-than-expected Q2 results and raised its FY16 outlook.
Merck & Co., Inc. MRK shares gained 7.8 percent to reach a new 52-week high of $62.37 after Bristol-Myers Squibb Co BMY reported results from the CheckMate-026 Study, stating cancer-treating Opdivo did not meet the primary endpoint.
Nu Skin Enterprises, Inc. NUS shares rose 7.2 percent to touch a new 52-week high of $57.48. Nu Skin posted in-line quarterly earnings, but sales exceeded analysts’ estimates. The company also raised its Q3 earnings guidance.
Acxiom Corporation ACXM shares touched a new 52-week high of $25.494 after the company reported better-than-expected quarterly results and raised its buyback plan by $100 million to $400 million. Acxiom reported a deal to sell Impact email unit.